Glucagon Market Size & Share | Trends Report, 2024 – 2032

Glucagon Market - By Product Type (Injectable, Inhalation), Application (Hypoglycemia, Diagnostic Aid, Gastrointestinal Disorders), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Global Forecast (2024 – 2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp;Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp;Research design

1.2.1&nbsp;&nbsp;&nbsp;Research approach

1.2.2&nbsp;&nbsp;&nbsp;Data collection methods

1.3&nbsp;&nbsp;&nbsp;Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp;Base year calculation

1.3.2&nbsp;&nbsp;&nbsp;Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp;Forecast model

1.5&nbsp;&nbsp;&nbsp;Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp;Primary sources

1.5.2&nbsp;&nbsp;&nbsp;Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary 

2.1&nbsp;&nbsp;&nbsp;Industry 3600&nbsp;synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights 

3.1&nbsp;&nbsp;&nbsp;Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp;Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp;Growth drivers

3.2.2&nbsp;&nbsp;&nbsp;Rising prevalence of diabetes

3.2.3&nbsp;&nbsp;&nbsp;Increasing research &amp; development activities

3.2.4&nbsp;&nbsp;&nbsp;Growing demand for non-injectable emergency glycogen

3.2.5&nbsp;&nbsp;&nbsp;Advancements in pharmaceutical sector

3.2.6&nbsp;&nbsp;&nbsp;Industry pitfalls &amp; challenges

3.2.7&nbsp;&nbsp;&nbsp;Lack of consumer awareness

3.2.8&nbsp;&nbsp;&nbsp;Stringent regulatory framework

3.3&nbsp;&nbsp;&nbsp;Growth potential analysis

3.4&nbsp;&nbsp;&nbsp;Regulatory landscape

3.5&nbsp;&nbsp;&nbsp;Technological landscape

3.6&nbsp;&nbsp;&nbsp;Porter&#39;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.4&nbsp;&nbsp;&nbsp; Company matrix analysis

4.5&nbsp;&nbsp;&nbsp; Strategy outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product Type, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp;Key trends

5.2&nbsp;&nbsp;&nbsp;Injectable

5.3&nbsp;&nbsp;&nbsp;Inhalation

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp;Key trends

6.2&nbsp;&nbsp;&nbsp;Hypoglycemia

6.3&nbsp;&nbsp;&nbsp;Diagnostic aid

6.4&nbsp;&nbsp;&nbsp;Gastrointestinal disorders

6.5&nbsp;&nbsp;&nbsp;Cardiogenic shock

6.6&nbsp;&nbsp;&nbsp;Other applications

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Distribution Channel, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp;Key trends

7.2&nbsp;&nbsp;&nbsp;Hospital pharmacies

7.3&nbsp;&nbsp;&nbsp;Retail pharmacies

7.4&nbsp;&nbsp;&nbsp;Online pharmacies

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp;Key trends

8.2&nbsp;&nbsp;&nbsp;North America

8.2.1&nbsp;&nbsp;&nbsp;U.S.

8.2.2&nbsp;&nbsp;&nbsp;Canada

8.3&nbsp;&nbsp;&nbsp;Europe

8.3.1&nbsp;&nbsp;&nbsp;Germany

8.3.2&nbsp;&nbsp;&nbsp;UK

8.3.3&nbsp;&nbsp;&nbsp;France

8.3.4&nbsp;&nbsp;&nbsp;Spain

8.3.5&nbsp;&nbsp;&nbsp;Italy

8.3.6&nbsp;&nbsp;&nbsp;Netherlands

8.3.7&nbsp;&nbsp;&nbsp;Rest of Europe

8.4&nbsp;&nbsp;&nbsp;Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp;Japan

8.4.2&nbsp;&nbsp;&nbsp;China

8.4.3&nbsp;&nbsp;&nbsp;India

8.4.4&nbsp;&nbsp;&nbsp;Australia

8.4.5&nbsp;&nbsp;&nbsp;South Korea

8.4.6&nbsp;&nbsp;&nbsp;Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp;Latin America

8.5.1&nbsp;&nbsp;&nbsp;Brazil

8.5.2&nbsp;&nbsp;&nbsp;Mexico

8.5.3&nbsp;&nbsp;&nbsp;Argentina

8.5.4&nbsp;&nbsp;&nbsp;Rest of Latin America

8.6&nbsp;&nbsp;&nbsp;Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp;Saudi Arabia

8.6.2&nbsp;&nbsp;&nbsp;South Africa

8.6.3&nbsp;&nbsp;&nbsp;UAE

8.6.4&nbsp;&nbsp;&nbsp;Rest of Middle East and Africa

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles 

9.1&nbsp;&nbsp;&nbsp; Amgen Inc.

9.2&nbsp;&nbsp;&nbsp; Avalon Pharma Private Limited

9.3&nbsp;&nbsp;&nbsp; Bachem Holding AG

9.4&nbsp;&nbsp;&nbsp; Eli Lilly and Company

9.5&nbsp;&nbsp;&nbsp; Fresenius SE &amp; Co. KGaA

9.6&nbsp;&nbsp;&nbsp; Fujifilm Holdings Corporation

9.7&nbsp;&nbsp;&nbsp; Novo Nordisk A/S

9.8&nbsp;&nbsp;&nbsp; Pfizer, Inc.

9.9&nbsp;&nbsp;&nbsp; Svar Life Science

9.10&nbsp;&nbsp;&nbsp; Taj Pharmaceuticals Ltd.

9.11&nbsp;&nbsp;&nbsp; Xeris Biopharma Holdings, Inc.

&nbsp;&nbsp;&nbsp;

Glucagon Market

Get a free sample of this report